BlackRock Inc. Increases Stake in STAAR SURGICAL CO to 13.1%

On April 24, 2026, BlackRock, Inc. filed a Schedule 13G/A (Amendment No. 19) with the SEC, reporting a significant increase in its stake in STAAR SURGICAL CO (STAA). As of the event date on March 31, 2026, BlackRock beneficially owns 6,507,911 shares of common stock, representing a 13.1% ownership stake in the company. This marks a substantial rise from the previously reported 0% ownership in the provided data. BlackRock maintains sole dispositive power over all 6,507,911 shares and sole voting power over 6,453,653 shares. Notably, the filing identifies the iShares Core S&P Small-Cap ETF as an affiliate holding more than five percent of the total outstanding common stock. The acquisition was made in the ordinary course of business, without the intent to change or influence the control of the issuer. This filing highlights BlackRock's continued and expanded institutional commitment to STAAR SURGICAL CO, a leader in implantable lenses for the eye.